NCT05920863
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
- 1# Banshan East Rd. Zhejiang cancer hospital Hangzhou, Zhejiang, China
Clinical trial condition
Pharmorubicin
Explore clinical trials studying Pharmorubicin. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study